Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

SEER

Seer (SEER)

Seer Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SEER
DateHeureSourceTitreSymboleSociété
14/06/202422h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
14/06/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEERSeer Inc
11/06/202417h11GlobeNewswire Inc.Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker DiscoveryNASDAQ:SEERSeer Inc
02/06/202416h55GlobeNewswire Inc.Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection StudyNASDAQ:SEERSeer Inc
08/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEERSeer Inc
08/05/202422h05GlobeNewswire Inc.Seer Reports First Quarter 2024 Financial ResultsNASDAQ:SEERSeer Inc
08/05/202422h03GlobeNewswire Inc.Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic SolutionsNASDAQ:SEERSeer Inc
23/04/202422h05GlobeNewswire Inc.Seer to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:SEERSeer Inc
06/03/202422h14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SEERSeer Inc
29/02/202422h05GlobeNewswire Inc.Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 OutlookNASDAQ:SEERSeer Inc
21/02/202422h05GlobeNewswire Inc.Seer to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:SEERSeer Inc
06/02/202414h00GlobeNewswire Inc.Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker DiscoveryNASDAQ:SEERSeer Inc
01/02/202422h05GlobeNewswire Inc.Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024NASDAQ:SEERSeer Inc
03/01/202414h52Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SEERSeer Inc
21/12/202322h05GlobeNewswire Inc.Seer to Present at the J.P. Morgan 42nd Annual Health Care ConferenceNASDAQ:SEERSeer Inc
10/11/202315h00GlobeNewswire Inc.Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:SEERSeer Inc
08/11/202315h00GlobeNewswire Inc.Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500NASDAQ:SEERSeer Inc
07/11/202322h05GlobeNewswire Inc.Seer Reports Third Quarter 2023 Financial ResultsNASDAQ:SEERSeer Inc
01/11/202314h00GlobeNewswire Inc.Seer Announces Addition of Panome Bio to Centers of Excellence (COE) ProgramNASDAQ:SEERSeer Inc
19/10/202322h05GlobeNewswire Inc.Seer to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:SEERSeer Inc
08/09/202322h05GlobeNewswire Inc.Seer to Participate in Upcoming September Investor ConferencesNASDAQ:SEERSeer Inc
08/08/202322h05GlobeNewswire Inc.Seer Reports Second Quarter 2023 Financial ResultsNASDAQ:SEERSeer Inc
27/07/202322h05GlobeNewswire Inc.Seer to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:SEERSeer Inc
13/07/202322h05GlobeNewswire Inc.Seer to Report Second Quarter 2023 Financial Results on August 8, 2023NASDAQ:SEERSeer Inc
07/06/202315h00GlobeNewswire Inc.Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access CenterNASDAQ:SEERSeer Inc
01/06/202315h00GlobeNewswire Inc.Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their StudiesNASDAQ:SEERSeer Inc
19/05/202322h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEERSeer Inc
09/05/202322h33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SEERSeer Inc
09/05/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEERSeer Inc
09/05/202322h05GlobeNewswire Inc.Seer Reports First Quarter 2023 Financial ResultsNASDAQ:SEERSeer Inc
 Showing the most relevant articles for your search:NASDAQ:SEER